Generate Biomedicines, Inc. (GENB)
13.12
+0.03
(+0.23%)
USD |
NASDAQ |
May 29, 16:00
13.13
+0.01
(+0.08%)
After-Hours: 20:00
Generate Biomedicines EPS Diluted (Quarterly) : -0.5398 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -0.8121 |
| Beam Therapeutics, Inc. | -0.9134 |
| Arrowhead Pharmaceuticals, Inc. | -0.932 |
| Oncolytics Biotech, Inc. | -0.0823 |
| Sangamo Therapeutics, Inc. | -0.0796 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -61.71M |
| Revenue (Quarterly) | 7.224M |
| Total Expenses (Quarterly) | 68.67M |
| Enterprise Value | 1.231B |
| Gross Profit Margin (Quarterly) | 54.69% |
| Profit Margin (Quarterly) | -854.3% |
| Earnings Yield | -16.43% |